Dennis Bastas is the Executive Chairman and CEO of the Arrotex Australia Group of companies and Chairman of Juno Pharmaceuticals. In 2015, Dennis acquired the Arrow business, in partnership with Strides Pharmaceuticals, from Aspen Pharmaceuticals. After buying out the Strides ownership in 2019, he merged the business with Apotex Australia to form Arrotex Pharmaceuticals. Prior to this, Dennis founded Ascent Pharmaceuticals and as CEO went on to build a successful Australian and Asian generic pharmaceutical company which was ultimately sold to Actavis Pharmaceuticals. Dennis also developed the Central Healthcare group of companies in 2010, which he sold to Sigma Pharmaceuticals in 2014. Dennis is also the major shareholder and Chairman of myDNA, a world leading pharmacogenomic and health genomic platform technology.

Chairman & Group CEO, Arrotex Australia Group

DENNIS BASTAS

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by: